Urol. praxi. 2021;22(1):19-21 | DOI: 10.36290/uro.2021.003

New trends in urine cytology

MUDr. Martina Tomašov
Urosanté, Praha

Urine cytology is nothing new in the urological practice and it still remains to be a fundamental and widely used method for detection of urothelial carcinoma. The Paris classification system has changed the way of looking at the evaluation of urine cytology specimens. Its forthcoming revised version aims at following this trend.

Keywords: cytology, Paris classification, urothelial carcinoma.

Received: November 30, 2020; Revised: January 10, 2021; Accepted: January 12, 2021; Prepublished online: January 12, 2021; Published: April 15, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tomašov M. New trends in urine cytology. Urol. praxi. 2021;22(1):19-21. doi: 10.36290/uro.2021.003.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. The Paris system of Reporting Urinary Cytology: Strengths and opportunities - Kurtycz - 2020 - Diagnostic Cytopathology - Wiley Online Library. Accessed November 24, 2020. https://onlinelibrary.wiley.com/doi/abs/10.1002/dc.24561.
    2. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology - FullText - Acta Cytologica 2016; 60(3) - Karger Publishers. Accessed November 25, 2020. https://www.karger.com/Article/FullText/446270. Go to original source... Go to PubMed...
    3. Hwang EC, Park SH, Jung SI, et al. Usefulness of liquid-based preparation in urine cytology. Int J Urol. 2007; 14(7): 626-629. doi: https://doi.org/10.1111/j.1442-2042.2006.01731.x. Go to original source... Go to PubMed...
    4. Rosenthal DL, Wojcik EM, Kurtycz DFI, eds. The Paris System for Reporting Urinary Cytology. Springer International Publishing; 2016. doi: 10.1007/978-3-319-22864-8. Go to original source...
    5. Pivovarčíková K, Pitra T, Hora M, Švajdler M, Hes O. Aktuální pohled na močovou cytologii: co by měl urolog vědět? Ces Urol 2018; 22(4): 242-250.
    6. Wojcik EM. Paris System 2.0 (@ParisSystem2) / Twitter. Twitter. Accessed November 25, 2020. https://twitter.com/ParisSystem2.
    7. Koss LG, Deitch D, Ramanathan R, Sherman AB. Diagnostic value of cytology of voided urine. Acta Cytol 1985; 29(5): 810-816. Go to PubMed...
    8. Pitra T, Dikanová M, Hora M, Michal M, Hes O, Pivovarčíková K. Porovnání výsledků invazivních vyšetření a močové cytologie: zkušenosti jednoho urologického pracoviště po prvním roce užívání Pařížské klasifikace pro hodnocení močových cytologií. Ces Urol 2018; 22(4): 275-284.
    9. Piaton E, Decaussin-Petrucci M, Mege-Lechevallier F, Advenier A-S, Devonec M, Ruffion A. Diagnostic terminology for urinary cytology reports including the new subcategories "atypical urothelial cells of undetermined significance" (AUC-US) and "cannot exclude high grade" (AUC-H). Cytopathol Off J Br Soc Clin Cytol 2014; 25(1): 27-38. doi: 10.1111/cyt.12050. Go to original source... Go to PubMed...
    10. Sanghvi AB, Allen EZ, Callenberg KM, Pantanowitz L. Performance of an artificial intelligence algorithm for reporting urine cytopathology. Cancer Cytopathol 2019; 127(10): 658-666. doi: https://doi.org/10.1002/cncy.22176. Go to original source... Go to PubMed...
    11. Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 2011; 108(5): 701-705. doi: 10.1111/j.1464-410X.2010.09899.x. Go to original source... Go to PubMed...
    12. Zhang ML, VandenBussche CJ, Hang J-F, et al. A review of urinary cytology in the setting of upper tract urothelial carcinoma. J Am Soc Cytopathol. Published online 2020. doi: 10.1016/j.jasc.2020.06.011. Go to original source... Go to PubMed...
    13. Rouprêt M, Babjuk M, Burger M, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. Eur Urol. Published online June 24, 2020. doi: 10.1016/j.eururo.2020.05.042. Go to original source... Go to PubMed...
    14. Têtu B, Tiguert R, Harel F, Fradet Y. ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Mod Pathol Off J U S Can Acad Pathol Inc 2005; 18(1): 83-89. doi: 10.1038/modpathol.3800262. Go to original source... Go to PubMed...
    15. Iwata H, Sassa N, Kato M, et al. UroVysion® predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study. Int J Clin Oncol. Published online September 21, 2020. doi: 10.1007/s10147-020-01785-9. Go to original source... Go to PubMed...
    16. Vlajnic T, Gut A, Savic S, Bubendorf L. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH. J Clin Pathol 2020; 73(2): 90-95. doi: 10.1136/jclinpath-2019-206109. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.